A new genetic marker for schizophrenia

CHA Biotech affiliate wins FDA approval for Schizophrenia treatment

CMG Pharmaceutical, a chemical drug affiliate of CHA Biotech, has received approval from the U.S. Food and Drug Administration (FDA) for its schizophrenia treatment, Mezofy, the company said Wednesday. Mezofy is an oral film-type drug based on aripiprazole, a widely used antipsychotic for treating a variety of mood and psychotic disorders. This is the fourth case of a Korean pharmaceutical company securing approval for an incrementally modified …

A new genetic marker for schizophrenia

Scientists find a rare genetic variant that shows strong association with schizophrenia.

Evaluating and treating the prodromal stage of schizophrenia

Identification of a person in the prodromal stage of schizophrenia, before the onset of the first episode of psychosis, provides an opportunity for early,

Researchers Say LSD Analog Has Potential to Treat Schizophrenia

University of California, Davis researchers say they have developed a drug from LSD that promotes neuroplasticity and could be an effective schizophrenia treatment. The researchers created the drug, called JRT, by switching two atoms in the molecular structure of LSD - essentially "a tire rotation," according to co-author David E. Olson, director of the Institute for Psychedelics and Neurotherapeutics and a professor of chemistry, biochemistry, …

Probiotics for bipolar disorder and schizophrenia - National Elf Service

In her first Mental Elf blog, Dr Mary Butler discusses the use of probiotics for the treatment of bipolar disorder and schizophrenia.

Medications for Different Domains of Schizophrenia

Different medications for different domains: new treatments are changing the way schizophrenia is managed.